Does ATORVASTATIN Cause Immune thrombocytopenia? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Immune thrombocytopenia have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.
17
Reports of Immune thrombocytopenia with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Immune thrombocytopenia From ATORVASTATIN?
Of the 17 reports, 10 (58.8%) required hospitalization.
Is Immune thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Immune thrombocytopenia?
RITUXIMAB (335)
ALEMTUZUMAB (299)
PEMBROLIZUMAB (205)
DEXAMETHASONE (202)
ELTROMBOPAG OLAMINE (161)
NIVOLUMAB (151)
ROMIPLOSTIM (145)
OXALIPLATIN (141)
METHOTREXATE (132)
PREDNISONE (127)
Which ATORVASTATIN Alternatives Have Lower Immune thrombocytopenia Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM